References
- James PT. Obesity: the worldwide epidemic. Clin Dermatol. 2004;22:276–80.
- Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60:349–56.
- Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329–39.
- Odrowaz-Sypniewska G. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome. Adv Med Sci. 2007;52:246–50.
- Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol. 2006;64:355–65.
- Rehman J, Considine RV, Bovenkerk JE. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol. 2003;41:1408–13.
- Warnberg J, Marcos A. Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol. 2008;19:11–5.
- Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.
- Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971–7.
- Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97: 3–11A.
- McGill HC Jr., McMahan CA, Herderick EE. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr. 2000;72:1307–15S.
- Jarvisalo MJ, Harmoinen A, Hakanen M. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol. 2002;22:1323–8.
- Kapiotis S, Holzer G, Schaller G. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol. 2006;26:2541–6.
- Andersen LB, Wedderkopp N, Hansen HS. Biological cardiovascular risk factors cluster in Danish children and adolescents: the European Youth Heart Study. Prev Med. 2003;37:363–7.
- Saland JM. Update on the metabolic syndrome in children. Curr Opin Pediatr. 2007;19:183–91.
- Huang TT, Ball GD, Franks PW. Metabolic syndrome in youth: current issues and challenges. Appl Physiol Nutr Metab. 2007;32:13–22.
- Valle M, Martos R, Gascon F. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 2005;31:55–62.
- Aygun AD, Gungor S, Ustundag B. Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children. Mediators Inflamm. 2005;2005(3): 180–3.
- Shin JY, Kim SY, Jeung MJ. Serum adiponectin, C-reactive protein and TNF-αlpha levels in obese Korean children. J Pediatr Endocrinol Metab. 2008;21:23–9.
- Warnberg J, Moreno LA, Mesana MI. Inflammatory mediators in overweight and obese Spanish adolescents. The AVENA Study. Int J Obes Relat Metab Disord. 2004;28Suppl 3:S59–63.
- Herder C, Schneitler S, Rathmann W. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92:4569–74.
- Rubin DA, McMurray RG, Harrell JS. The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise. Metabolism. 2008;57:683–90.
- Winer JC, Zern TL, Taksali SE. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91:4415–23.
- Steene-Johannessen J, Kolle E, Anderssen SA. Cardiovascular disease risk factors in a population-based sample of Norwegian children and adolescents. Scand J Clin Lab Invest. 2009;69:380–6.
- Cole TJ, Bellizzi MC, Flegal KM. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240–3.
- Tanner JM. Growth at adolescence. Oxford: Blackwell; 1962.
- Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
- Yeh ET. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol. 2005;28:408–12.
- Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059–62.
- Zimmet P, Alberti G, Kaufman F. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059–61.
- Ford ES, Galuska DA, Gillespie C. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. J Pediatr. 2001;138:486–92.
- Wu DM, Chu NF, Shen MH. Obesity, plasma high sensitivity c-reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem. 2006;39:810–5.
- Warnberg J, Nova E, Moreno LA. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006;84:505–12.
- Guran O, Akalin F, Ayabakan C. High-sensitivity C-reactive protein in children at risk for coronary artery disease. Acta Paediatr. 2007;96:1214–9.
- Oliveira AC, Oliveira AM, Almeida MS. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth. J Pediatr. 2008;152:337–42.
- Soriano-Guillen L, Hernandez-Garcia B, Pita J. High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur J Endocrinol. 2008;159:R1–4.
- Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest. 2007;117:2362–8.
- Bell LN, Ward JL, Degawa-Yamauchi M. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab. 2006;291:E843–8.
- Hiratsuka A, Adachi H, Fujiura Y. Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab. 2005;90:2927–31.
- Jimenez MV, Estepa RM, Camacho RMM. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol. 2007;156:497–502.
- Balagopal P, George D, Patton N. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr. 2005;146:342–8.